ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.44167
0.15%
Brent Oil
84.695
-0.11%
Bitcoin
64,833.30
-0.47%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSXV
  6. Cotec Holdings Corp (CTH)

  7. Cotec Holdings Corp (CTH) Noticias

CTH

Cotec (CTH)

Cotec Holdings Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSXV:CTH
FechaHoraFuenteTítuloSímboloCompañía
19/11/201408:35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
19/11/201408:33PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
18/11/201415:12PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
18/11/201415:10PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
17/07/201415:15Marketwired CanadaCynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesTSXV:CTHCotec Holdings Corp
08/07/201405:00Marketwired CanadaCynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's ResearchTSXV:CTHCotec Holdings Corp
20/05/201415:42MarketwiredCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
14/05/201405:00MarketwiredCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
07/05/201416:30Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
24/04/201405:00MarketwiredCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
15/04/201409:27Marketwired CanadaCynapsus Therapeutics Completes $25,000,000 Short Form Prospectus OfferingTSXV:CTHCotec Holdings Corp
08/04/201421:14Marketwired CanadaCynapsus Therapeutics Files Final Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201415:50Marketwired CanadaCynapsus Therapeutics Files Preliminary Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201405:00MarketwiredCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
27/03/201415:00MarketwiredCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/02/201408:22MarketwiredCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
13/02/201407:00MarketwiredCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
07/02/201408:15MarketwiredLifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.TSXV:CTHCotec Holdings Corp
23/01/201415:00MarketwiredCynapsus Therapeutics Announces Exercise of WarrantsTSXV:CTHCotec Holdings Corp
22/01/201415:30MarketwiredCynapsus Announces Resignation of Chief Scientific OfficerTSXV:CTHCotec Holdings Corp
13/01/201405:00MarketwiredCynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277TSXV:CTHCotec Holdings Corp
26/11/201307:00Marketwired CanadaSeeThruEquity, LLC Initiates Coverage on Cynapsus Therapeutics Inc.TSXV:CTHCotec Holdings Corp
21/11/201314:42Marketwired CanadaCynapsus Therapeutics Reports Third Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
10/10/201310:04Marketwired CanadaGoldquest, Micromem Technologies, Cynapsus Therapeutics and Excalibur Resources Featured on Episode 14 of the Next Biggest Wi...TSXV:CTHCotec Holdings Corp
22/08/201315:17Marketwired CanadaCynapsus Therapeutics Reports Second Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
18/07/201306:00Marketwired CanadaCynapsus Therapeutics Begins Trading on the OTCQX Marketplace in the United StatesTSXV:CTHCotec Holdings Corp
30/05/201308:00Marketwired CanadaCynapsus Therapeutics to Present at the SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 10:00 AM EDTTSXV:CTHCotec Holdings Corp
23/05/201308:28Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
15/05/201305:00Marketwired CanadaCynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative Deliv...TSXV:CTHCotec Holdings Corp
09/05/201315:45Marketwired CanadaCynapsus Therapeutics Appoints Two New DirectorsTSXV:CTHCotec Holdings Corp
 Showing the most relevant articles for your search:TSXV:CTH

Su Consulta Reciente

LATK
THNUSDT
Throne
TG
A3KPB1
VGP NV
NASDAQI
XSOX
PHLX Semiconductor Secto...
NASDAQ
AACQ
Artius Acquisition
EU
EBSWP
EN ESG Biodiversity Scre...
NYSE
TNP.PRF
Tsakos Energy Navigation Ltd.
COIN
DEKUUST
DekuInu
USOTC
BRCHF
BrainChip (QX)
COIN
FXTETH
BOV
PEAB4R
PAR AL BAHIA PN
USOTC
SBFFY
SBM Offshore NV (PK)
BIT
I07251
INTESA SANPAOLO
TG
DRE2
Deutsche Real Estate
TG
A28V31
JAB Holdings BV
USOTC
HCKG
Hocking Valley Bancshares (PK)
TSXV
ETK.H
Envirotek Remediation
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados